Comparison of the efficacy of aerosolized inhalation of different doses of recombinant human interferon alpha1b combined with budesonide in the treatment of asthmatic bronchitis in children
High-dose (3.0 µg/kg) IFNα1b combined with budesonide has certain advantages in improving cough, wheezing, pulmonary rales, pulmonary function, and immune status in children with AB, providing new clinical references for treatment.
Authors
- Yong Chen (ORCID: https://orcid.org/0000-0002-3486-6553)
- Long Huang (ORCID: https://orcid.org/0000-0002-4154-6734)
- Qin Zhang (ORCID: https://orcid.org/0000-0001-5173-2920)
- Dandan Li (ORCID: https://orcid.org/0000-0001-9346-3212)
- Kangkang Li (ORCID: https://orcid.org/0000-0001-6041-7041)
- Hui Lei (ORCID: https://orcid.org/0000-0002-9448-9673)
Institutions
- Maternal and Child Health Hospital of Sichuan Province (CN)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3389/fped.2025.1642786
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00